Skip to main content
Premium Trial:

Request an Annual Quote

Caliper s Revenues Triple, Net Loss Remains Stable in Q1

NEW YORK, May 7 (GenomeWeb News) - Caliper Life Sciences reported three times increased revenues for the first quarter today, while losses remained stable.

 

Revenues were $16.9 million, up from $5.6 million during the same period last year. This increase was mainly due to revenues from Zymark, which Caliper acquired last July.

 

Research and development costs decreased to $6.5 million, from $9.4 million during the same quarter in 2003.

 

Caliper's net loss for the quarter was $10 million, or $.35 per share, compared to $10 million, or $.4 per share, during the year-ago period.

 

At the end of March, Caliper had $5.6 million in cash and cash equivalents, and $50.3 million in marketable securities.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.